Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Bioequivalence studies: Biowaivers

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The best words in the best order.

Nature·2011

Same author

Career decisions: Taking the plunge.

Nature·2011

Same author

Protein-protein interactions: Interactome under construction.

Nature·2010

Same author

Protein-protein interactions: Tools for the search.

Nature·2010

Same author

Protein-protein interactions: Real-time analysis.

Nature·2010

Same author

Biomedical science: Putting research into practice.

Nature·2010

Search research articles

Related Experiment Video

Updated: May 6, 2026

Visualizing Visual Adaptation

Visualizing Visual Adaptation

Published on: April 24, 2017

Enhancing NIH grant peer review: a broader perspective.

|October 30, 2008

Summary

This summary is machine-generated.

The National Institutes of Health (NIH) is updating its grant review process. These changes will align NIH procedures with European funding models while preserving unique aspects.

More Related Videos

Using Looming Visual Stimuli to Evaluate Mouse Vision

Using Looming Visual Stimuli to Evaluate Mouse Vision

Published on: June 13, 2019

Non-aversive Animal Restraint Enabling Recording of Optomotor Reflex in Ground Squirrels

Non-aversive Animal Restraint Enabling Recording of Optomotor Reflex in Ground Squirrels

Published on: July 25, 2025

Related Experiment Videos

Last Updated: May 6, 2026

Visualizing Visual Adaptation

Visualizing Visual Adaptation

Published on: April 24, 2017

Using Looming Visual Stimuli to Evaluate Mouse Vision

Using Looming Visual Stimuli to Evaluate Mouse Vision

Published on: June 13, 2019

Non-aversive Animal Restraint Enabling Recording of Optomotor Reflex in Ground Squirrels

Non-aversive Animal Restraint Enabling Recording of Optomotor Reflex in Ground Squirrels

Published on: July 25, 2025

Area of Science:

Biomedical research funding
Grant administration

Background:

The National Institutes of Health (NIH) manages a significant biomedical research grant system.
Current NIH grant application review processes are established but undergoing revision.

Purpose of the Study:

To inform stakeholders about upcoming changes to the NIH grant review process.
To highlight the planned modifications in grant application evaluation.

Main Methods:

Analysis of planned procedural adjustments by the NIH.
Comparison of proposed NIH review mechanisms with international models, particularly European funding agencies.

Main Results:

NIH grant review will incorporate elements similar to European funding agencies.
The revised NIH system will maintain distinctive features alongside new adaptations.

Conclusions:

The NIH is evolving its grant review system to enhance efficiency and international alignment.
Stakeholders should prepare for modifications in NIH grant application submission and review over the next few years.